US20100076470A1 - Methods and Devices for Sheath Compression - Google Patents

Abstract

A sheath is configured for elongation from a first length to a second, longer length and a retention member retains the sheath at the first length. A portion of the retention member is removed or disengaged, the sheath is released and expands in situ to the second longer length. A method for releasing the retention member is also disclosed.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
• This application claims priority to, and the benefit of, U.S. Provisional Patent Application Ser. No. 61/099,015 filed on Sep. 22, 2008; U.S. patent application Ser. No. 12/486,333 filed Jun. 17, 2009, which claims priority to U.S. Provisional Patent Application Ser. No. 61/079,198, filed on Jul. 9, 2008; U.S. patent application Ser. No. 12/486,346 filed Jun. 17, 2009, which claims priority to U.S. Provisional Patent Application Ser. No. 61/079,200, filed on Jul. 9, 2008; U.S. patent application Ser. No. 12/486,352 filed Jun. 17, 2009, which claims priority to U.S. Provisional Patent Application Ser. No. 61/079,202, filed on Jul. 9, 2008, the entire content of which are incorporated herein by reference.
TECHNICAL FIELD
• The present disclosure relates to a sheath for use with an anastomosis, and more particularly to sheaths in a compressed position for delivery to a surgical site.
BACKGROUND
• An anastomosis, or the joining of two vessels, such as esophagus, colon, or other parts of the digestive tract, is a common procedure. Sheaths may be placed over the anastomotic site to protect the anastomotic site during healing.
• Specific patient populations such as patients with diabetes T1, T2, or other immuno-compromised patients (such as chemotherapy patients) are more prone to anastomotic leaks. These patient populations have longer healing profiles and sometimes weaker immune systems and these factors may lead to an increase in leak occurrence. Unfortunately, in most cases, anastomotic leaks are not detected until clinical symptoms present themselves.
• Copending, commonly assigned patent applications 61/079,198, 61/079,200, and 61/079,202 disclose various embodiments of sheaths which may assist in decreasing leaks and the risks associated with anastomotic leaks. However, it would be advantageous to retain the sheath in a compressed position at least for insertion.
SUMMARY
• Medical devices, and more particularly sheaths are described herein which provide for protection of an anastomosis and more particularly sheaths which are provided in a compressed position for at least insertion. The sheath is configured for elongation in situ from a first length to a second, longer length; the sheath is provided in combination with a retention member, the retention members retaining the sheath at the first length. In some embodiments, upon disengagement of at least a portion of the retention member from the sheath, the sheath is capable of elongation longitudinally from the first length to the second, longer length. In other embodiments, upon removal of at least a portion of the retention member, the sheath extends to the second, longer length. Alternatively, upon severing of the retention member, the sheath may elongate from the first length to the second, longer length.
• In one alternate embodiment, a sheath includes a distal portion and a proximal portion, and the sheath is retained in a first position having a first length for insertion into a body lumen and is elongated to a second position having a second greater length for placement in a body lumen, the distal portion of the sheath longitudinally extending past an anastomotic site. Furthermore, the sheath may be retained in the first position by a retention member.
• Retention members of the present disclosure are selected from the group consisting of fibers, sutures, clips, pins, and staples. The retention members may also be glues or adhesives. The retention member may penetrate at least a portion of the sleeve. Materials which may be used to make the retention member include materials selected from the group consisting of polysaccharides, proteins, vinyl polymers, PEG-based polymers, and combinations thereof. The retention member may also be water soluble. In some embodiments, the retention member may be in the form of a polymer coating. In other embodiments, the retention member encapsulates the sheath.
• A method of treating a patient is also disclosed, the method including the steps of providing a sheath having a distal end and a proximal end, the sheath configured for elongation in situ from first length to a second, longer length, and a retention member; attaching the proximal end of the sheath to a body lumen at a region proximal of an anastomosis; and, releasing the retention member so the sheath is extendable to the second length. The method may further include the step of grasping the sheath and applying a force to extend the sheath distally past an anastomotic site.
BRIEF DESCRIPTION OF THE DRAWINGS
• Various preferred embodiments of the medical devices are described herein with reference to the drawings, in which:
• FIG. 1A is a cross-sectional view of a sheath in a compressed position, with a retention member intact;
• FIG. 1B is a cross-sectional view of the sheath ofFIG. 1 in an expanded position, after the retention member ofFIG. 1A has been severed;
• FIGS. 2A-2D are side views of different embodiments of sheath retention members according to the present disclosure;
• FIG. 3A is a cross-sectional perspective view of the device ofFIG. 2C in a first compressed position, with the retention member intact; and,
• FIG. 3B is another cross-sectional perspective view of the device ofFIG. 2C after the retention member has been severed.
DETAILED DESCRIPTION OF EMBODIMENTS
• The present disclosure is directed to a retention member which retains an anastomotic sheath at a first length for insertion into a body lumen, and upon disengagement or release of the retention member, the sheath may elongate in situ to a second, longer length. The term “sheath” as used herein includes a medical device defining a passage, which allows for the transport and flow of fluids therethrough. The term “body lumen” as used herein, means an inner open space of cavity of a tubular organ, such as a blood vessel, intestine, or esophagus. The term “proximal” as used herein means portion of the device which is closer to the user, while the term “distal” refers to a portion of the device which is further from the user.
• FIG. 1 illustrates a cross-sectional view of asheath12 positioned in abody lumen20, proximal of ananastomotic site22. A proximal portion of thesheath12 includes aring member14 and a distal portion of the sheath includes asleeve16, which is subsequently elongated distally past ananastomotic site22. Thesheath12 is held in a compressed position by aretention member10. Theretention member10 is an elongate polymeric member, e.g. a suture, which is positioned on an interior surface of thesheath12. Alternately, theretention member10 may be positioned exterior of thesheath12. A first portion of theretention member10ais connected to thering member14 at afirst connection point13a,and a second portion of theretention member10bis connected to thesleeve16 at a second connection point13, thesecond connection point13bbeing distal to thefirst connection point13a.Theretention member10 may be connected to thesheath12 at least two connection points (13a,13b) which enable to sheath be retained in a compressed position. For example, a first connection point may be located at a proximal portion of the sheath and a second connection point may be located at a distal portion of the sheath. At least one retention member10 (two are shown) may be used to retain thesheath12 in a first, compressed position for insertion. It is also envisioned that more than tworetention members10 may be used to retain thesheath12 in a compressed position. Additionally, theretention member10 may include more than two connection points (13a,13b), which may enable a more uniform compression of thesheath12. Theretention member10 may be connected to thesheath12 using any method within the purview of those skilled in the art including, but not limited to welding, tacking or gluing.
• Thesheath12 may be inserted into abody lumen20 in a first compressed position, through use of an insertion device (not shown). Once inserted and positioned in abody lumen20 proximal to ananastomotic site22, theretention member10 may be severed, for example, along line A-A, releasing thesheath12 from a compressed position (FIG. 1B). Thesheath12 may then self expand or elongate distally past ananastomosis22. Alternately, a separate device, such as a grasper (not shown), may be used to extend a length of thesleeve16 distally past an anastomotic site.
• Various alternate embodiments of retention members are illustrated inFIGS. 2A-2D.FIG. 2A shows asheath40 in a compressed position. Thesheath40 includes aring member42 and asleeve44, thesleeve44 extending distally from thering member42. Thering member42 is generally rigid so as to maintain thesheath40 in a fixed position in situ, applying radial pressure to a body lumen. Thesheath40 is retained in a compressed position by aretention member46, as shown inFIG. 2A. Theretention member46 is a suture which is wrapped around aninner portion40aand anouter portion40bof the sheath and ends of thesuture46 are fastened or knotted together at46a,creating a closed loop around thesheath40.FIG. 2A shows tworetention members46 positioned about180 degrees apart, so as to uniformly confine thesheath40 to a shorter length at least for insertion. Theretention members46 may be moveably (i.e. slideably) positioned on the sheath40 (as shown). Alternately, theretention members46 may be positioned at a fixed location or series of locations along the circumference of thesheath40. It is also contemplated that more than tworetention members46 may be used to confine thesheath40 to a shorter length. Once thesheath40 is positioned in a body lumen, a user may sever and optionally remove theretention members46. Thesheath40 may then be elongated distally past an anastomotic site, enabling fluids to bypass the anastomotic site and protecting the anastomotic site throughout the wound healing cycle. It should also be understood that although the illustrated sheaths have a ring member, various embodiments of sheaths, with or without ring members, may be used in combination with the retention members of the present disclosure.
• The sheaths shown inFIGS. 2B-2D are similar, with various embodiments of retention members.FIG. 2B illustratesretention members150 being formed surgical staples having a generally “B”-shaped geometry. Theretention members150 have at least two legs (150a) which are connected therebetween by abackspan150b.It should be noted that although the legs of the staples (150a,150b) overlap exterior to the sheath, the legs of the staples (150a) may overlap on theinterior portion140aof thesheath140, with the backspan150bpositioned exterior to thesheath140. Tworetention members150 are shown positioned approximately 180 degrees apart so as to uniformly compress thesheath140. It is contemplated that more than tworetention members150 may be used to retain thesheath140 in a compressed position. Theretention members150 may be positioned at a fixed location or series of locations along the circumference of the sheath140 (as shown). Alternately, theretention members150 may be slideably positioned on thesheath140. In one embodiment, theretention members150 may be shape memory polymeric or metallic surgical staples, which once positioned in situ, theretention members150 may self expand upon reaching body temperature, releasing thesheath140 from a compressed position and enabling thesheath140 to longitudinally extend to a second position (not shown). Theretention members150 may be removed from the body once thesheath140 has been released.
• Alternatively, the retention members may be pins or strings which pierce at least a portion of the sheath.FIG. 2C illustrates thesheath240 in which thesleeve244 is rolled proximally, towards thering member242.FIG. 3A illustrates a cross-sectional view of the sheath240 (ofFIG. 2C), including aretention member260 which defines an elongate body, such as a pin or a suture, penetrating at least a portion of thesheath240. More specifically, thesleeve244 defines anouter wall244bandinner wall244a,the distance between which defines a wall thickness w2. Thering member242 also has a wall thickness w1, which is the diameter of thering member242, thering member242 being circular in cross-sectional area. Theretention member260 penetrates at least a portion of the sleeve and the ring member.
• Theretention member260 includes at least two ends, a first end of theretention member260 penetrates the wall thickness w2 of thesleeve240, and a second end of theretention member260 penetrates at least a portion of the wall thickness w1 of thering member242. Alternatively, theretention member260 may only penetrate thesleeve244. Theelongate body260 runs through the walls of thesleeve244 andring member242, connecting the first end to the second end. As shown, the retention member penetrates thesheath240 along a centerline. The ends of theretention member260 may include a portion which is tacked or welded at260ato thesleeve244. Alternatively, at least oneend260bof theretention member260 may be secured to thesheath240 by piercing the sheath wall and knotting or tying the ends of theretention member260. Theretention member260 retains thesheath240 in a compressed position and the two ends of theelongate body260 prevent the sheath from unraveling. When at least one end of the retention member is severed (FIG. 3B), thesheath240 may be elongated distally past an anastomotic site. It should be noted that although theretention member260 penetrates bothsleeve244 and thering member242, theretention member260 may penetrate thesheath240 at any point or series of points, which enables thesheath240 to be restricted in a compressed position.
• In another embodiment, aretention member370 may encapsulate at least a portion of thesheath340. For example, as shown inFIG. 2D, theretention member370 may be similar to a balloon or a net, surrounding or encapsulating theentire sheath340, maintaining thesheath340 in a compressed position. Theretention member370 may be severed or pierced and theretention member370 may be removed in situ, allowing the sheath to expand to a second, longer length. In some embodiments, theretention member370 may comprise a water soluble material, e.g. gelatin or cellulose, wherein theretention member370 may dissolve upon contact with fluids and thesheath340 can be longitudinally extended past an anastomotic site.
• In alternate embodiments, retention members may include polymeric materials which, for example, upon drying, would assist in maintaining the sheath in a compressed state. For example, certain polymeric materials, including polymer solutions, may be processed with the sheath. The sheath may be folded, rolled, or crimped into a compressed position. The sheath may then be dried in an oven or at ambient temperature and upon evaporation of the polymer solution, the dried polymer coating (retention member), retains the sheath in a shorter, compressed position. Upon implantation into tissue, the retention member may wet or hydrate, allowing the sheath to expand into a second, longer position. Suitable polymeric materials include but are not limited to those listed below including polysaccharides such as starch, alginate or chitosan and water soluble adhesives. Suitable water soluble adhesives include succinimide-based PEG esters, photocurable vinyl adhesives and aldehydes.
• Retention members may comprise both absorbable and non absorbable materials, which may be synthetic or natural materials. Suitable synthetic absorbable materials include polymers such as those made from lactide, glycolide, caprolactone, valerolactone, carbonates (e.g., trimethylene carbonate, tetramethylene carbonate, and the like), dioxanones (e.g., 1,4-dioxanone) δ-valerolactone, 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), ethylene glycol, ethylene oxide, esteramides, γ-hydroxyvalerate, β-hydroxypropionate, alpha-hydroxy acid, hydroxybuterates, orthoesters, hydroxy alkanoates, tyrosine carbonates, polyimide carbonates, polyimino carbonates such as poly (bisphenol A-iminocarbonate) and poly (hydroquinone-iminocarbonate), and polymer drugs (e.g., polydiflunisol, polyaspirin, and protein therapeutics) and copolymers and combinations thereof. Suitable natural absorbable polymers include, fibrin, proteins (e.g. albumin, collagen, gelatin, casein, lactoferrin), and gut and combinations thereof. Additionally, polysaccharides may also be used to as retention members, including agarose, cellulose, carboxymethyl cellulose, methyl cellulose, dextran (e.g. carboxylated dextran, aminated dextran, sulfonated dextran), alginates, chitosan, hyaluronic acid, and fucans. Synthetic polymers and natural polymers may also be combined to make retention members of the enclosed disclosure.
• Suitable non-absorbable materials which may be used to form the retention member include non-absorbable natural materials such as cotton, silk, and rubber. Suitable non-absorbable synthetic materials include monomers and polymers derived from materials such as nylons, polyolefins such as polypropylene and polyethylene, ultra high molecular weight polyethylene (UHMWPE), polyamides, polyesters such as poly ethylene terepththalate (PET), polyaryletherketone, polyvinylidene difluoride (PVDF), acrylics such as poly acrylic acid, aramids, fluoropolymers, polybutesters, silicones, and polymer blends, copolymers thereof and combinations with degradable polymers. Hydrophilic vinyl polymers and copolymers such as acrylic acid, polyvinyl pyrrolidone, methacrylic acid, potassium sulfopropyl acrylates, bisacrylates, methacrylates including hydroxyethyl methacrylate (HEMA), methacryloyloxyethyl phosphorylcholine (MPC), acrylamide, polypyrrole, vinyl acetate, styrene sulfonic, and hydroxyamates may also be employed as suitable materials for retention members. Combinations and copolymers of various non-absorbable materials may also be used as retention members. Additionally, non-absorbable synthetic and natural polymers and monomers may be combined with each other and may also be combined with various absorbable polymers and monomers to create the retention member.
• In other embodiments, the retention member may be constructed using shape memory materials. A thermal shape memory material may be used in certain described embodiments, such as the staple-shaped retention member, where upon temperature activation of a material, the retention member opens and releases a portion of the sheath, allowing it to elongate. Suitable polymers used to prepare hard and soft segments of shape memory polymers include polycaprolactone, dioxanone, lactide, glycolide, polyacrylates, polyamides, polysiloxanes, polyurethanes, polyether amides, polyurethane/ureas, polyether esters, and urethane/butadiene copolymers and combinations thereof.
• Absorbable metallic materials may also be used to construct retention members. Suitable absorbable metals and metal alloys include magnesium-based and iron-based alloys. The magnesium-based alloys may additionally include about 1 to 10 wt. % scandium, up to about 3 wt. % yttrium, about 1 to 3 wt. % rare earth metal, and about 0.1 to 0.5 wt. % zirconium.
• It should be noted that the present disclosure is not limited to use with specific sheaths for use with colonic and intestinal anastomoses and contemplates retaining other sheath embodiments. Additionally, the above description contains many specifics; these specifics should not be construed as limitations on the scope of the disclosure herein but merely as exemplifications of particularly useful embodiments thereof. Those skilled in the art will envision many other possibilities within the scope and spirit of the disclosure as defined by the claims appended hereto.

Claims (16)

1. A medical device comprising:

a sheath configured for elongation in situ from a first length to a second, longer length; and,

a retention member, wherein the retention member retains the sheath at the first length.

2. The medical device according toclaim 1, wherein upon disengagement of at least a portion of the retention member from the sheath, the sheath is capable of elongation longitudinally from the first length to the second, longer length.

3. The medical device according toclaim 1, wherein upon removal of at least a portion of the retention member, the sheath extends to the second, longer length.

4. The medical device according toclaim 1, wherein upon severing of the retention member, the sheath may elongate from the first length to the second, longer length.

5. The medical device according toclaim 1, wherein the retention member is selected from the group consisting of fibers, sutures, clips, pins, and staples.

6. The medical device according toclaim 1, wherein the retention member penetrates at least a portion of the sleeve.

7. The medical device according toclaim 1, wherein the retention member comprises a material selected from the group consisting of polysaccharides, proteins, vinyl polymers, PEG-based polymers, and combinations thereof.

8. The medical device ofclaim 1, wherein the retention member is a polymer coating.

9. The medical device according toclaim 1, wherein the retention member encapsulates the sheath.

10. A medical device comprising:

a sheath having a distal portion and a proximal portion, wherein the sheath is retained in a first position having a first length for insertion into a body lumen and is elongated to a second position having a second greater length for placement in a body lumen, the distal portion of the sheath longitudinally extending past an anastomotic site.

11. The medical device according toclaim 10, wherein the sheath is retained in the first position by a retention member.

12. The medical device according toclaim 11, wherein the retention member is selected from the group consisting of fibers, sutures, clips, pins, and staples.

13. The medical device according toclaim 11, wherein the retention member is selected from the group consisting of glues and adhesives.

14. The medical device according toclaim 13, wherein the retention member is water soluble.

15. A method of treating a patient, comprising the steps of:

providing a sheath having a distal end and a proximal end, the sheath configured for elongation in situ from first length to a second, longer length, and a retention member;

attaching the proximal end of the sheath to a body lumen at a region proximal of an anastomosis; and,

releasing the retention member so the sheath is extendable to the second length.

16. The method ofclaim 15, further comprising the step of grasping the sheath and applying a force to extend the sheath distally past an anastomotic site.

Images